Autolus Therapeutics plc American Depositary Share

Last updated September 27, 2026

Organization details

Legal name
Autolus Therapeutics plc American Depositary Share
Former names
Autolus Therapeutics Ltd
Ownership
Public
Status
Active
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
United Kingdom
Headquarters city
London
Headquarters country
United Kingdom
Fiscal year end
December
Ticker symbol
AUTL
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001730463

Board of directors

Chief executives

Christian Itin · Chief Executive Officer
Since March 2026

Board connections

6 of this board's directors also sit on 12 other boards.

Network of Autolus Therapeutics plc American Depositary Share's board connections ADC Therapeutics SA ADC Therapeutics SA Alnylam Pharmaceuticals Inc. Alnylam Pharmaceutical... Arvinas Inc. Arvinas Inc. Cardinal Health Inc. Cardinal Health Inc. Century Therapeutics Inc. Century Therapeutics I... Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Immunic Inc. Immunic Inc. Olema Pharmaceuticals Inc. Olema Pharmaceuticals... Pliant Therapeutics Inc. Pliant Therapeutics In... Praxis Precision Medicines Inc. Praxis Precision Medic... Tango Therapeutics Inc. Tango Therapeutics Inc... UroGen Pharma Ltd. UroGen Pharma Ltd. Cynthia M. Butitta Cynthia M. Butitta Linda Bain Linda Bain Michael W. Bonney Michael W. Bonney Robert Azelby Robert Azelby Robert Iannone Robert Iannone William D. Young William D. Young Autolus Therapeutics plc A...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$15,682
1 sale by 1 insider
Date Insider Transaction Shares Price Value
Sep 2, 2026 Piccina Cintia Officer (U.S. CCO & Country Gen Manager) Open-market sale −6,713 $2.34 $15,682
Sep 1, 2026 Piccina Cintia Officer (U.S. CCO & Country Gen Manager) Option exercise +20,000 $2.35 $47,000

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.